William Conkling Protara Therapeutics, Inc. (TARA) insider trading activity

William Conkling is Chief Commercial Officer of Protara Therapeutics, Inc.. Currently has a direct ownership of 50,000 shares of TARA, which is worth approximately $166,500. The most recent transaction as insider was on Jun 02, 2025, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50K

n/a 3M change

n/a 12M change

Total Value Held $166,500

WILLIAM CONKLING Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 02 2025	BUY Grant, award, or other acquisition	-	50,000 Added 50.0%	50,000 Common Stock

Also insider at

RFL

Rafael Holdings, Inc. Real Estate

Chief Executive Officer

CYTH

Cyclo Therapeutics, Inc. Healthcare

Director